Clinuvel Pharmaceuticals Ltd.
Australian biopharma Clinuvel develops SCENESSE, a photoprotective drug for erythropoietic protoporphyria, and a pipeline of melanocortin‑based therapies, targeting rare genetic and metabolic disorders worldwide.
Headquarters: Australia (AUS)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- HQ: Melbourne
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.